JNJ WD — Johnson & Johnson Cashflow Statement
0.000.00%
- $397.54bn
- $415.90bn
- $94.94bn
- 82
- 38
- 57
- 62
Annual cashflow statement for Johnson & Johnson, fiscal year end - January 1st, USD millions except per share, conversion factor applied.
2018 December 30th | 2019 December 29th | 2021 January 3rd | 2022 January 2nd | 2023 January 1st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 15,297 | 15,119 | 14,714 | 20,878 | 17,941 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 988 | -101 | 42 | 1,459 | 1,957 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 3 | 3,865 | 2,690 | -4,238 | -4,011 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 22,201 | 23,416 | 23,536 | 23,410 | 21,194 |
Capital Expenditures | -3,670 | -3,498 | -3,347 | -3,652 | -4,009 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 503 | -2,696 | -17,478 | -5,031 | -8,362 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -3,167 | -6,194 | -20,825 | -8,683 | -12,371 |
Financing Cash Flow Items | -148 | 575 | -627 | 395 | 65 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -18,510 | -18,015 | -6,120 | -14,047 | -8,871 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 283 | -802 | -3,320 | 502 | -360 |